Literature DB >> 11286821

Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome.

N Müller1, B Kroll, M J Schwarz, M Riedel, A Straube, R Lütticken, R R Reinert, T Reineke, O Kühnemund.   

Abstract

It has been suggested that a post-streptococcal autoimmune process may be involved in the pathogenesis of a subgroup of children with tics and obsessive-compulsive symptoms (PANDAS). Elevated antibody titers against streptococcal antigens have also been described in adult patients suffering from Tourette's syndrome (TS). In order to characterise further streptococcal antigens, we focussed on M proteins. M proteins are a major virulence factor of group A streptococci and known to evoke an immunologic cross-reaction with diverse epitopes of human tissue including brain tissue. Therefore, antibodies against M proteins may play a role in the pathophysiology of at least a subgroup of TS patients. Antibodies against M proteins were studied in 25 adult patients suffering from TS and 25 healthy controls after careful medical examination. The antibody titers against the peptides M1, M4, M6, M12 and M19 were estimated by ELISA. Our results show increased titers of antibodies against the streptococcal M12 and M19 proteins in TS patients as compared with controls, while antibody titers against M1, M4 and M6 did not differ between the TS and control groups. Elevated serum titers of antibodies against M12 and M19 proteins support the view that a streptococcus-induced autoimmune process may be involved in TS. The finding of a possible autoimmune origin of TS has implications for both pathophysiology and future therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286821     DOI: 10.1016/s0165-1781(01)00215-3

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

1.  Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.

Authors:  A J Church; R C Dale; A J Lees; G Giovannoni; M M Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

2.  Identification of pyruvate kinase as an antigen associated with Tourette syndrome.

Authors:  Janice W Kansy; Liliya Katsovich; Kevin S McIver; Jennifer Pick; John B Zabriskie; Paul J Lombroso; James F Leckman; James A Bibb
Journal:  J Neuroimmunol       Date:  2006-10-02       Impact factor: 3.478

3.  Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens.

Authors:  Mauro Bombaci; Renata Grifantini; Marirosa Mora; Valerio Reguzzi; Roberto Petracca; Eva Meoni; Sergio Balloni; Chiara Zingaretti; Fabiana Falugi; Andrea G O Manetti; Immaculada Margarit; James M Musser; Francesco Cardona; Graziella Orefici; Guido Grandi; Giuliano Bensi
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

Review 4.  Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches.

Authors:  Norbert Müller
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

5.  Association of Tic Disorders and Enterovirus Infection: A Nationwide Population-Based Study.

Authors:  Ching-Shu Tsai; Yao-Hsu Yang; Kuo-You Huang; Yena Lee; Roger S McIntyre; Vincent Chin-Hung Chen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder.

Authors:  Najmeh Shahini; Ali Talaei; Mohammadreza Shalbafan; Farhad Faridhosseini; Maliheh Ziaee
Journal:  Basic Clin Neurosci       Date:  2021-07-01

7.  M-protein and other intrinsic virulence factors of Streptococcus pyogenes are encoded on an ancient pathogenicity island.

Authors:  Alexandre Panchaud; Lionel Guy; François Collyn; Marisa Haenni; Masanobu Nakata; Andreas Podbielski; Philippe Moreillon; Claude-Alain H Roten
Journal:  BMC Genomics       Date:  2009-04-27       Impact factor: 3.969

Review 8.  Maternal immune activation and neuroinflammation in human neurodevelopmental disorders.

Authors:  Velda X Han; Shrujna Patel; Hannah F Jones; Russell C Dale
Journal:  Nat Rev Neurol       Date:  2021-08-02       Impact factor: 42.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.